Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain

Journal of Neuroscience

Volumn 32, Issue 32, 2012, Pages 11082-11094

  Gleichman, Amy J ^a,b   Spruce, Lynn A ^b   Dalmau, Josep ^a,c   Seeholzer, Steven H ^b   Lynch, David R ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLUTAMATE RECEPTOR 1;

AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; ANTIGEN BINDING; ARTICLE; BIOTINYLATION; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOGENICITY; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; MALE; MASS SPECTROMETRY; MUTAGENESIS; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; RAT; SITE DIRECTED MUTAGENESIS;

AGE FACTORS; ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; ANTIBODIES; BINDING SITES, ANTIBODY; BIOTINYLATION; BRAIN; CELL LINE, TRANSFORMED; EPITOPES; FEMALE; GLUTAMIC ACID; GLYCINE; GLYCOSYLATION; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOPRECIPITATION; MALE; MEMBRANE POTENTIALS; MUTAGENESIS, SITE-DIRECTED; MUTATION; PATCH-CLAMP TECHNIQUES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE; STATISTICS, NONPARAMETRIC; TANDEM MASS SPECTROMETRY; TRANSFECTION; TUNICAMYCIN;

EID: 84864836764     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0064-12.2012     Document Type: Article

References (70)

1. Akazawa C, Shigemoto R, Bessho Y, Nakanishi S, Mizuno N (1994) Differential expression of five N-methyl-D-aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats. J Comp Neurol 347: 150-160.
2. Chapman MR, Vause HE (2011) Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment. Am J Psychiatry 168:245-251.
3. Chazot PL, Cik M, Stephenson FA (1995) An investigation into the role of N-glycosylation in the functional expression of a recombinant heteromeric NMDA receptor. Mol Membr Biol 12:331-337.
4. Colquhoun D, Sakmann B (1985) Fast events in single-channel currents activated by acetylcholine and its analogues at the frog muscle end-plate. J Physiol 369:501-557.
5. Coyle JT (2006) Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol 26:365-384.
6. Cull-Candy SG, Leszkiewicz DN (2004) Role of distinct NMDA receptor subtypes at central synapses. Sci STKE 2004:re16.
7. Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, Mason W, Sansing LH, Dichter MA, Rosenfeld MR, Lynch DR (2007) Paraneoplastic anti-N-methyl-Daspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61:25-36.
8. Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR (2008) Anti-NMDAreceptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091-1098.
9. Dalva MB, Takasu MA, Lin MZ, Shamah SM, Hu L, Gale NW, Greenberg ME (2000) EphB receptors interact with NMDA receptors and regulate excitatory synapse formation. Cell 103:945-956.
10. DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B (2001) A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 7:1189-1193.
11. Dingledine R, Borges K, Bowie D, Traynelis SF (1999) The glutamate receptor ion channels. Pharmacol Rev 51:7-61.
12. Doyle HA, Mamula MJ (2001) Post-translational protein modifications in antigen recognition and autoimmunity. Trends Immunol 22:443-449.
13. Erreger K, Dravid SM, Banke TG, Wyllie DJ, Traynelis SF (2005) Subunitspecific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signalling profiles. J Physiol 563:345-358.
14. Everts I, Villmann C, Hollmann M (1997) N-Glycosylation is not a prerequisite for glutamate receptor function but is essential for lectin modulation. Mol Pharmacol 52:861-873.
15. Farina AN, Blain KY, Maruo T, Kwiatkowski W, Choe S, Nakagawa T (2011) Separation of domain contacts is required for heterotetrameric assembly of functional NMDA receptors. J Neurosci 31:3565-3579.
16. Finke C, Kopp UA, Prüss H, Dalmau J, Wandinger KP, Ploner CJ (2012) Cognitive deficits following anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry 83:195-198.
17. Florance NR, Davis RL, Lam C, Szperka C, Zhou L, Ahmad S, Campen CJ, Moss H, Peter N, Gleichman AJ, Glaser CA, Lynch DR, Rosenfeld MR, Dalmau J (2009) Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 66:11-18.
18. Furukawa H (2012) Structure and function of glutamate receptor amino terminal domains. J Physiol 590:63-72.
19. Gielen M, Siegler Retchless B, Mony L, Johnson JW, Paoletti P (2009) Mechanism of differential control ofNMDAreceptor activity by NR2 subunits. Nature 459:703-707.
20. Gonzalez J, Takao T, Hori H, Besada V, Rodriguez R, Padron G, Shimonishi Y (1992) A method for determination of N-glycosylation sites in glycoproteins by collision-induced dissociation analysis in fast atom bombardment mass spectrometry: identification of the positions of carbohydrate-linked asparagine in recombinant alpha-amylase by treatment with peptide-N-glycosidase F in 18O-labeled water. Anal Biochem 205:151-158.
21. Grigoriadis DE, De Souza EB (1989) Heterogeneity between brain and pituitary corticotropin-releasing factor receptors is due to differential glycosylation. Endocrinology 125:1877-1888.
22. Hansen KB, Furukawa H, Traynelis SF (2010) Control of assembly and function of glutamate receptors by the amino-terminal domain. Mol Pharmacol 78:535-549.
23. Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Tsou R, Parsons TD, Lynch DR, Dalmau J, Balice-Gordon RJ (2010) Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 30:5866-5875.
24. Huh KH, Wenthold RJ (1999) Turnover analysis of glutamate receptors identifies a rapidly degraded pool of the N-methyl-D-aspartate receptor subunit, NR1, in cultured cerebellar granule cells. J Biol Chem 274:151-157.
25. Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS, Friese MA, Galea I, Kullmann DM, Beeson D, Lang B, Bien CG, Vincent A (2010) N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133:1655-1667.
26. Jansen EF, Nutting MDF, Jang R, Balls AK (1949) Inhibition of the proteinase and esterase activities of trypsin and chymotrypsin by diisopropyl fluorophosphate; crystallization of inhibited chymotrypsin. J Biol Chem 179:189-199.
27. Jin R, Singh SK, Gu S, Furukawa H, Sobolevsky AI, Zhou J, Jin Y, Gouaux E (2009) Crystal structure and association behaviour of the GluR2 aminoterminal domain. EMBO J 28:1812-1823.
28. Jing L, Chu XP, Jiang YQ, Collier DM, Wang B, Jiang Q, Snyder PM, Zha XM (2012) N-glycosylation of acid-sensing ion channel 1a regulates its trafficking and acidosis-induced spine remodeling. J Neurosci 32: 4080-4091.
29. Karakas E, Simorowski N, Furukawa H (2009) Structure of the zinc-bound amino-terminal domain of the NMDA receptor NR2B subunit. EMBO J 28:3910-3920.
30. Karakas E, Simorowski N, Furukawa H (2011) Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors. Nature 475:249-253.
31. Kashyape P, Taylor E, Ng J, Krishnakumar D, Kirkham F, Whitney A (2012) Successful treatment of two paediatric cases of anti-NMDA receptor encephalitis with Cyclophosphamide: the need for early aggressive immunotherapy in tumour negative paediatric patients. Eur J Paediatr Neurol 16:74-78.
32. Kayser MS, Dalmau J (2011) The emerging link between autoimmune disorders and neuropsychiatric disease. J Neuropsychiatry Clin Neurosci 23:90-97.
33. Keller A, Nesvizhskii AI, Kolker E, Aebersold R (2002) Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 74:5383-5392.
34. Kornfeld R, Kornfeld S (1985) Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 54:631-664.
35. Laurie DJ, Putzke J, Zieglgansberger W, Seeburg PH, Tolle TR (1995) The distribution of splice variants of theNMDAR1subunitmRNAin adult rat brain. Brain Res Mol Brain Res 32:94-108.
36. Lauvsnes MB, Omdal R (2012) Systemic lupus erythematosus, the brain, and anti-NR2 antibodies. J Neurol 259:622-629.
37. Lindstrom J (2002) Autoimmune diseases involving nicotinic receptors. J Neurobiol 53:656-665.
38. Makarova O, Kamberov E, Margolis B (2000) Generation of deletion and point mutations with one primer in a single cloning step. Biotechniques 29:970-972.
39. McIlhinney RA, Le Bourdelles B, Molnar E, Tricaud N, Streit P, Whiting PJ (1998) Assembly intracellular targeting and cell surface expression of the human N-methyl-D-aspartate receptor subunits NR1a and NR2A in transfected cells. Neuropharmacology 37:1355-1367.
40. Meddows E, Le Bourdelles B, Grimwood S, Wafford K, Sandhu S, Whiting P, McIlhinney RA (2001) Identification of molecular determinants that are important in the assembly of N-methyl-D-aspartate receptors. J Biol Chem 276:18795-18803.
41. Molberg O, McAdam SN, Korner R, Quarsten H, Kristiansen C, Madsen L, Fugger L, Scott H, Noren O, Roepstorff P, Lundin KE, Sjostrom H, Sollid LM (1998) Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 4:713-717.
42. Moss CX, Matthews SP, Lamont DJ, Watts C (2005) Asparagine deamidation perturbs antigen presentation on class II major histocompatibility complex molecules. J Biol Chem 280:18498-18503.
43. Murphy DE, Schneider J, Boehm C, Lehmann J, Williams M (1987) Binding of [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid to rat brain membranes: a selective, high-affinity ligand for N-methyl-Daspartate receptors. J Pharmacol Exp Ther 240:778-784.
44. Nesvizhskii AI, Keller A, Kolker E, Aebersold R (2003) A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 75:4646-4658.
45. Palmiter RD, Cole TB, Quaife CJ, Findley SD (1996) ZnT-3, a putative transporter of zinc into synaptic vesicles. Proc Natl Acad Sci U S A 93:14934-14939.
46. Paoletti P (2011) Molecular basis of NMDA receptor functional diversity. Eur J Neurosci 33:1351-1365.
47. Paschen W, Widmann R, Weber C (1992) Changes in regional polyamine profiles in rat brains after transient cerebral ischemia (single versus repetitive ischemia): evidence for release of polyamines from injured neurons. Neurosci Lett 135:121-124.
48. Plested AJ, Groot-Kormelink PJ, Colquhoun D, Sivilotti LG (2007) Singlechannel study of the spasmodic mutation alpha1A52S in recombinant rat glycine receptors. J Physiol 581:51-73.
49. Prüss H, Dalmau J, Harms L, Holtje M, Ahnert-Hilger G, Borowski K, Stoecker W, Wandinger KP (2010) Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology 75:1735-1739.
50. Prüss H, Holtje M, Maier N, Gomez A, Buchert R, Harms L, Ahnert-Hilger G, Schmitz D, Terborg C, Kopp U, Klingbeil C, Probst C, Kohler S, Schwab JM, Stoecker W, Dalmau J, Wandinger KP (2012) IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment. Neurology 78:1743-1753.
51. Raju R, Foote J, Banga JP, Hall TR, Padoa CJ, Dalakas MC, Ortqvist E, Hampe CS (2005) Analysis of GAD65 autoantibodies in Stiff-Person syndrome patients. J Immunol 175:7755-7762.
52. Robinson NE, Robinson A (2004) Molecular clocks: deamidation of asparaginyl and glutaminyl residues in peptides and proteins. Cave Junction, OR: Althouse.
53. Robinson NE, Robinson ZW, Robinson BR, Robinson AL, Robinson JA, Robinson ML, Robinson AB (2004) Structure-dependent nonenzymatic deamidation of glutaminyl and asparaginyl pentapeptides. J Pept Res 63:426-436.
54. Rubio-Agusti I, Dalmau J, Sevilla T, Burgal M, Beltran E, Bataller L (2011) Isolated hemidystonia associated with NMDA receptor antibodies. Mov Disord 26:351-352.
55. Sanchez-Perez A, Llansola M, Cauli O, Felipo V (2005) Modulation of NMDA receptors in the cerebellum. II. Signaling pathways and physiological modulators regulating NMDA receptor function. Cerebellum 4:162-170.
56. Sobolevsky AI, Rosconi MP, Gouaux E (2009) X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor. Nature 462:745-756.
57. Stocca G, Vicini S (1998) Increased contribution of NR2A subunit to synaptic NMDA receptors in developing rat cortical neurons. J Physiol 507:13-24.
58. Storey GP, Opitz-Araya X, Barria A (2011) Molecular determinants controlling NMDA receptor synaptic incorporation. J Neurosci 31:6311-6316.
59. Stroebel D, Carvalho S, Paoletti P (2011) Functional evidence for a twisted conformation of the NMDA receptor GluN2A subunit N-terminal domain. Neuropharmacology 60:151-158.
60. Tang HY, Ali-Khan N, Echan LA, Levenkova N, Rux JJ, Speicher DW (2005) A novel four-dimensional strategy combining protein and peptide separation methods enables detection of low-abundance proteins in human plasma and serum proteomes. Proteomics 5:3329-3342.
61. Tzartos SJ, Barkas T, Cung MT, Mamalaki A, Marraud M, Orlewski P, Papanastasiou D, Sakarellos C, Sakarellos-Daitsiotis M, Tsantili P, Tsikaris V (1998) Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor. Immunol Rev 163:89-120.
62. Wang Z, Danscher G, Kim YK, Dahlstrom A, Mook Jo S (2002) Inhibitory zinc-enriched terminals in the mouse cerebellum: double-immunohistochemistry for zinc transporter 3 and glutamate decarboxylase. Neurosci Lett 321:37-40.
63. Watanabe M, Inoue Y, Sakimura K, Mishina M (1992) Developmental changes in distribution of NMDA receptor channel subunit mRNAs. Neuroreport 3:1138-1140.
64. Willson CA, Foster RD, Onifer SM, Whittemore SR, Miranda JD (2006) EphB3 receptor and ligand expression in the adult rat brain. J Mol Histol 37:369-380.
65. Wu HY, Hsu FC, Gleichman AJ, Baconguis I, Coulter DA, Lynch DR (2007) Fyn-mediated phosphorylation of NR2B Tyr-1336 controls calpainmediated NR2B cleavage in neurons and heterologous systems. J Biol Chem 282:20075-20087.
66. Wyllie DJ, Johnston AR, Lipscombe D, Chen PE (2006) Single-channel analysis of a point mutation of a conserved serine residue in the S2 ligandbinding domain of the NR2A NMDA receptor subunit. J Physiol 574: 477-489.
67. Yamakura T, Shimoji K (1999) Subunit- and site-specific pharmacology of the NMDA receptor channel. Prog Neurobiol 59:279-298.
68. Yamamoto M, Yamamoto F, Luong TT, Williams T, Kominato Y (2003) Expression profiling of 68 glycosyltransferase genes in 27 different human tissues by the systematic multiplex reverse transcription-polymerase chain reaction method revealed clustering of sexually related tissues in hierarchical clustering algorithm analysis. Electrophoresis 24:2295-2307.
69. Yuan H, Hansen KB, Vance KM, Ogden KK, Traynelis SF (2009) Control of NMDA receptor function by the NR2 subunit amino-terminal domain. J Neurosci 29:12045-12058.
70. Zhang Q, Tanaka K, Sun P, Nakata M, Yamamoto R, Sakimura K, Matsui M, Kato N (2012) Suppression of synaptic plasticity by cerebrospinal fluid from anti-NMDA receptor encephalitis patients. Neurobiol Dis 45:610-615.